Synopsis
0
EU WC
0
KDMF
0
VMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Thickeners and Stabilizers
Parenteral
Controlled & Modified Release
Film Formers & Plasticizers
Granulation
Emulsifying Agents
Direct Compression
Coating Systems & Additives
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
49
PharmaCompass offers a list of Gramicidin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gramicidin manufacturer or Gramicidin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gramicidin manufacturer or Gramicidin supplier.
PharmaCompass also assists you with knowing the Gramicidin API Price utilized in the formulation of products. Gramicidin API Price is not always fixed or binding as the Gramicidin Price is obtained through a variety of data sources. The Gramicidin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Neosporin Ophthalmic Solution manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neosporin Ophthalmic Solution, including repackagers and relabelers. The FDA regulates Neosporin Ophthalmic Solution manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neosporin Ophthalmic Solution API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Neosporin Ophthalmic Solution manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Neosporin Ophthalmic Solution supplier is an individual or a company that provides Neosporin Ophthalmic Solution active pharmaceutical ingredient (API) or Neosporin Ophthalmic Solution finished formulations upon request. The Neosporin Ophthalmic Solution suppliers may include Neosporin Ophthalmic Solution API manufacturers, exporters, distributors and traders.
click here to find a list of Neosporin Ophthalmic Solution suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Neosporin Ophthalmic Solution DMF (Drug Master File) is a document detailing the whole manufacturing process of Neosporin Ophthalmic Solution active pharmaceutical ingredient (API) in detail. Different forms of Neosporin Ophthalmic Solution DMFs exist exist since differing nations have different regulations, such as Neosporin Ophthalmic Solution USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Neosporin Ophthalmic Solution DMF submitted to regulatory agencies in the US is known as a USDMF. Neosporin Ophthalmic Solution USDMF includes data on Neosporin Ophthalmic Solution's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Neosporin Ophthalmic Solution USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Neosporin Ophthalmic Solution suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Neosporin Ophthalmic Solution Drug Master File in Japan (Neosporin Ophthalmic Solution JDMF) empowers Neosporin Ophthalmic Solution API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Neosporin Ophthalmic Solution JDMF during the approval evaluation for pharmaceutical products. At the time of Neosporin Ophthalmic Solution JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Neosporin Ophthalmic Solution suppliers with JDMF on PharmaCompass.
A Neosporin Ophthalmic Solution CEP of the European Pharmacopoeia monograph is often referred to as a Neosporin Ophthalmic Solution Certificate of Suitability (COS). The purpose of a Neosporin Ophthalmic Solution CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Neosporin Ophthalmic Solution EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Neosporin Ophthalmic Solution to their clients by showing that a Neosporin Ophthalmic Solution CEP has been issued for it. The manufacturer submits a Neosporin Ophthalmic Solution CEP (COS) as part of the market authorization procedure, and it takes on the role of a Neosporin Ophthalmic Solution CEP holder for the record. Additionally, the data presented in the Neosporin Ophthalmic Solution CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Neosporin Ophthalmic Solution DMF.
A Neosporin Ophthalmic Solution CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Neosporin Ophthalmic Solution CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Neosporin Ophthalmic Solution suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Neosporin Ophthalmic Solution as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Neosporin Ophthalmic Solution API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Neosporin Ophthalmic Solution as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Neosporin Ophthalmic Solution and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Neosporin Ophthalmic Solution NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Neosporin Ophthalmic Solution suppliers with NDC on PharmaCompass.
Neosporin Ophthalmic Solution Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neosporin Ophthalmic Solution GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neosporin Ophthalmic Solution GMP manufacturer or Neosporin Ophthalmic Solution GMP API supplier for your needs.
A Neosporin Ophthalmic Solution CoA (Certificate of Analysis) is a formal document that attests to Neosporin Ophthalmic Solution's compliance with Neosporin Ophthalmic Solution specifications and serves as a tool for batch-level quality control.
Neosporin Ophthalmic Solution CoA mostly includes findings from lab analyses of a specific batch. For each Neosporin Ophthalmic Solution CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neosporin Ophthalmic Solution may be tested according to a variety of international standards, such as European Pharmacopoeia (Neosporin Ophthalmic Solution EP), Neosporin Ophthalmic Solution JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neosporin Ophthalmic Solution USP).
